Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Recurrence and CTLA4[original query] |
|---|
| Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases. The pharmacogenomics journal 2015 Mar . Stremitzer S, Sunakawa Y, Zhang W, Yang D, Ning Y, Stintzing S, Sebio A, Yamauchi S, Matsusaka S, El-Khoueiry R, Stift J, Wrba F, Gruenberger T, Lenz H |
| Signal peptide missense variant in cancer-brake gene CTLA4 and breast cancer outcomes. Gene 2020 Feb 737 144435. Babteen Nouf Abubakr, Fawzy Manal S, Alelwani Walla, Alharbi Raed A, Alruwetei Abdulmohsen M, Toraih Eman A, Elshazli Rami |
| A TP53-based immune prognostic model for muscle-invasive bladder cancer. Aging 2020 12 13 (2): 1929-1946. Li Hongyan, Lu Huayi, Cui Wanli, Huang Yufan, Jin Xuef |
| Characterization of CD66b and its relationship between immune checkpoints and their synergistic impact in the prognosis of surgically resected lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2021 9 160 84-91. Shen Mingjing, Jiang Kanqiu, Sui Yiqun, Xu Zhonghua, Cui Hongxia, Wang Youyou, Zhang Huan, Xu Zhonghen, Xu Weihua, Ding Qifeng, Chen Yongbi |
| Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer. Breast cancer research and treatment 2021 6 189 (1): 187-202. Ademuyiwa Foluso O, Chen Ina, Luo Jingqin, Rimawi Mothaffar F, Hagemann Ian S, Fisk Bryan, Jeffers Gejae, Skidmore Zachary L, Basu Anamika, Richters Megan, Ma Cynthia X, Weilbaecher Katherine, Davis Jennifer, Suresh Rama, Peterson Lindsay L, Bose Ron, Bagegni Nusayba, Rigden Caron E, Frith Ashley, Rearden Timothy P, Hernandez-Aya Leonel F, Roshal Anna, Clifton Katherine, Opyrchal Mateusz, Akintola-Ogunremi Olaronke, Lee Byung Ha, Ferrando-Martinez Sara, Church Sarah E, Anurag Meenakshi, Ellis Matthew J, Gao Feng, Gillanders William, Griffith Obi L, Griffith Malac |
| The Role of m5C-Related lncRNAs in Predicting Overall Prognosis and Regulating the Lower Grade Glioma Microenvironment. Frontiers in oncology 2022 4 12 814742. Zhou Hongshu, Meng Ming, Wang Zeyu, Zhang Hao, Yang Liting, Li Chuntao, Zhang Liya |
| Integrated analysis of single-cell and bulk RNA sequencing identifies a signature based on macrophage marker genes involved in prostate cancer prognosis and treatment responsiveness. Functional & integrative genomics 2023 4 23 (2): 115. Li Xiugai, Zheng Chang, Xue Xiaoxia, Wu Junying, Li Fei, Song Dan, Li Xueli |
| Comprehensive analysis of integrin ?v?3/?6?1 in prognosis and immune escape of prostate cancer. Aging 2023 10 15 . Yang Liu, Jia-Xin He, Bo Ji, Jin-Feng Wang, Lu Zhang, Zhong-Qi Pang, Jian-She Wang, Bei-Chen Ding, Ming-Hua R |
| CTLA4 genetic variants associated with urothelial bladder cancer susceptibility. Urologic oncology 2024 6 . Alexsandro Koike, Andréa Name Colado Simão, Tainah Mendes Ahrens, Kaue de Morais Cardoso, Beatriz Rabello Espinosa, Roberson Henrique Gobanhi Gualberto, Daniel Felipe Piva Santos, Guilherme Lerner Trigo, Edna Maria Vissoci Reiche, Marcell Alysson Batisti Lozov |
- Page last reviewed:Feb 1, 2024
- Content source: